{"id":753,"date":"2026-09-01T16:45:45","date_gmt":"2026-09-01T16:45:45","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"},"modified":"2026-09-01T16:45:45","modified_gmt":"2026-09-01T16:45:45","slug":"thymosin-alpha-1-tests-phase-3-sepsis-trial-2025","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/ja\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","title":{"rendered":"\u6557\u8840\u75c7\u306e Thymosin Alpha-1: 2025 TESTS \u30d5\u30a7\u30fc\u30ba 3 \u306e\u7d50\u679c"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">2025 TESTS \u8a66\u9a13\u306f\u3001\u4ee5\u524d\u306e\u5c0f\u898f\u6a21\u306a\u6557\u8840\u75c7\u5831\u544a\u3088\u308a\u3082\u6709\u76ca\u3067\u3059\u30021,106 \u6210\u4eba\u306f 22 \u65bd\u8a2d\u5168\u4f53\u3067\u30e9\u30f3\u30c0\u30e0\u5316\u3055\u308c\u3001\u30c1\u30e2\u30b7\u30f3 \u03b1-1 \u306f 28 \u306e\u5168\u65e5\u6b7b\u56e0\u6b7b\u4ea1\u7387\u3092\u4f4e\u4e0b\u3055\u305b\u307e\u305b\u3093\u3067\u3057\u305f\u3002<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">\u4e00\u76ee\u3067\u308f\u304b\u308b\u8a3c\u62e0<\/h2><ul class=\"wp-block-list\"><li>\u3053\u306e\u8a66\u9a13\u3067\u306f\u30011,106\u4eba\u306e\u6210\u4eba\u3092\u7121\u4f5c\u70ba\u306b\u5272\u308a\u4ed8\u3051\u305f\u3002 1,089 \u306f\u4fee\u6b63\u3055\u308c\u305f\u6cbb\u7642\u610f\u56f3\u5206\u6790\u306b\u542b\u307e\u308c\u3066\u3044\u307e\u3057\u305f\u3002<\/li><li>28 \u65e5\u5f8c\u306e\u6b7b\u4ea1\u7387\u306f\u3001\u30c1\u30e2\u30b7\u30f3 \u03b1-1 \u7fa4\u3067\u306f 23.4%\u3001\u30d7\u30e9\u30bb\u30dc\u7fa4\u3067\u306f 24.1% \u3067\u3057\u305f\u3002<\/li><li>\u30cf\u30b6\u30fc\u30c9\u6bd4\u306f 0.99 (95% CI 0.77\u20131.27; P=0.93) \u3067\u3001\u526f\u6b21\u7684\u30a2\u30a6\u30c8\u30ab\u30e0\u307e\u305f\u306f\u5b89\u5168\u6027\u30a2\u30a6\u30c8\u30ab\u30e0\u306b\u6709\u610f\u306a\u5dee\u7570\u306f\u3042\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp\" alt=\"\u307b\u307c\u91cd\u8907\u3059\u308b\u7d50\u679c\u3092\u4f34\u3046\u591a\u65bd\u8a2d\u4e8c\u7fa4\u6557\u8840\u75c7\u8a66\u9a13\u30c7\u30fc\u30bf\u306e\u8996\u899a\u5316\" class=\"wp-image-737\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-300x169.webp 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-1024x576.webp 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-768x432.webp 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence-1536x864.webp 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">\u30aa\u30ea\u30b8\u30ca\u30eb\u306e\u7de8\u96c6\u8abf\u67fb\u30a4\u30e9\u30b9\u30c8\u3002\u3053\u308c\u306f\u3001\u7814\u7a76\u56f3\u3001\u60a3\u8005\u753b\u50cf\u3001\u88fd\u54c1\u5199\u771f\u3001\u63d0\u4f9b\u3055\u308c\u305f\u5206\u6790\u7d50\u679c\u3001\u307e\u305f\u306f\u30ab\u30bf\u30ed\u30b0\u30ed\u30c3\u30c8\u306e\u8868\u73fe\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/figcaption><\/figure><h2 class=\"wp-block-heading\">\u5b66\u7fd2\u8a18\u9332<\/h2><p class=\"wp-block-paragraph\">\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u306f28\u65e5\u4ee5\u5185\u306e\u5168\u6b7b\u56e0\u6b7b\u4ea1\u3067\u3057\u305f\u3002\u30cf\u30b6\u30fc\u30c9\u6bd4\u304c\u4e00\u306b\u8fd1\u304f\u3001\u4fe1\u983c\u533a\u9593\u304c\u4e00\u3092\u307e\u305f\u3044\u3067\u3044\u308b\u305f\u3081\u3001\u8a66\u9a13\u96c6\u56e3\u5168\u4f53\u3067\u6b7b\u4ea1\u7387\u304c\u4f4e\u4e0b\u3057\u305f\u3053\u3068\u3092\u793a\u3059\u660e\u78ba\u306a\u8a3c\u62e0\u306f\u5f97\u3089\u308c\u3066\u3044\u307e\u305b\u3093\u3002<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>\u30c7\u30b6\u30a4\u30f3<\/strong><span>\u591a\u65bd\u8a2d\u5171\u540c\u3001\u4e8c\u91cd\u76f2\u691c\u3001\u30e9\u30f3\u30c0\u30e0\u5316\u3001\u30d7\u30e9\u30bb\u30dc\u5bfe\u7167\u76f8 3<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u30b5\u30a4\u30c8<\/strong><span>\u4e2d\u56fd\u306e22\u30bb\u30f3\u30bf\u30fc<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u4fee\u6b63\u3055\u308c\u305fITT<\/strong><span>542 \u30c1\u30e2\u30b7\u30f3 \u03b1-1; 547 \u30d7\u30e9\u30bb\u30dc<\/span><\/div><div class=\"pim-evidence-row\"><strong>28\u65e5\u6b7b\u4ea1\u7387<\/strong><span>23.4% \u5bfe 24.1%<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u52b9\u679c\u63a8\u8a08<\/strong><span>HR 0.99; 95% CI 0.77\u20131.27; P=0.93<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">\u30b3\u30f3\u30c6\u30ad\u30b9\u30c8\u5185\u306e\u7d50\u679c<\/h2><p class=\"wp-block-paragraph\">\u5e74\u9f62\u304a\u3088\u3073\u7cd6\u5c3f\u75c5\u306b\u3088\u308b\u4e8b\u524d\u306b\u6307\u5b9a\u3055\u308c\u305f\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u306e\u76f8\u4e92\u4f5c\u7528\u306b\u3088\u308a\u3001\u7570\u306a\u308b\u30b7\u30b0\u30ca\u30eb\u304c\u751f\u6210\u3055\u308c\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u306f\u5c06\u6765\u306e\u7814\u7a76\u3092\u8a08\u753b\u3059\u308b\u306e\u306b\u5f79\u7acb\u3061\u307e\u3059\u304c\u3001\u4e2d\u7acb\u7684\u306a\u4e00\u6b21\u7d50\u679c\u3092\u8986\u3059\u3082\u306e\u3067\u306f\u306a\u3044\u305f\u3081\u3001\u78ba\u7acb\u3055\u308c\u305f\u9069\u5fdc\u75c7\u3068\u3057\u3066\u5ba3\u4f1d\u3059\u3079\u304d\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p><p class=\"wp-block-paragraph\">2025 \u30e1\u30bf\u5206\u6790\u3067\u306f\u30011,927 \u53c2\u52a0\u8005\u306b\u3088\u308b 11 \u30e9\u30f3\u30c0\u30e0\u5316\u8a66\u9a13\u3092\u30d7\u30fc\u30eb\u3057\u3001\u5168\u4f53\u306e\u30aa\u30c3\u30ba\u6bd4 0.73 \u3092\u767a\u898b\u3057\u307e\u3057\u305f\u3002\u3057\u304b\u3057\u3001\u305d\u306e\u9ad8\u54c1\u8cea\u3067\u591a\u65bd\u8a2d\u306e\u30b5\u30d6\u30bb\u30c3\u30c8\u306f\u7d71\u8a08\u7684\u306b\u6709\u610f\u3067\u306f\u306a\u304f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u9010\u6b21\u5206\u6790\u3067\u306f\u5229\u7528\u53ef\u80fd\u306a\u30b5\u30f3\u30d7\u30eb\u306f\u4e0d\u9069\u5207\u3067\u3042\u308b\u3068\u5224\u65ad\u3055\u308c\u307e\u3057\u305f\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u5927\u304d\u306a TESTS \u306e\u7d50\u679c\u306f\u3001\u73fe\u5728\u306e\u30b5\u30de\u30ea\u30fc\u306e\u4e2d\u5fc3\u306b\u5c5e\u3057\u307e\u3059\u3002<\/p><h2 class=\"wp-block-heading\">\u8a3c\u62e0\u304c\u8a3c\u660e\u3067\u304d\u306a\u3044\u3082\u306e<\/h2><p class=\"wp-block-paragraph\">1 \u3064\u306e\u56fd\u5185\u8a66\u9a13\u304c\u3059\u3079\u3066\u306e\u533b\u7642\u5236\u5ea6\u3084\u6557\u8840\u75c7\u306e\u8868\u73fe\u578b\u3092\u4ee3\u8868\u3057\u3066\u3044\u308b\u3068\u306f\u9650\u308a\u307e\u305b\u3093\u3002<\/p><p class=\"wp-block-paragraph\">\u30b5\u30d6\u30b0\u30eb\u30fc\u30d7\u52b9\u679c\u306f\u78ba\u8a8d\u304c\u5fc5\u8981\u3067\u3042\u308a\u3001\u4eee\u8aac\u751f\u6210\u3092\u7d9a\u3051\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p><p class=\"wp-block-paragraph\">\u5b8c\u4e86\u3057\u305f\u4ecb\u5165\u306e\u81e8\u5e8a\u8a66\u9a13\u306f\u3001\u7121\u95a2\u4fc2\u306a\u7814\u7a76\u30ed\u30c3\u30c8\u3092\u691c\u8a3c\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>2025 TESTS \u8a66\u9a13\u306f\u3001\u4ee5\u524d\u306e\u5c0f\u898f\u6a21\u306a\u6557\u8840\u75c7\u5831\u544a\u3088\u308a\u3082\u6709\u76ca\u3067\u3059\u30021,106 \u6210\u4eba\u306f 22 \u65bd\u8a2d\u5168\u4f53\u3067\u30e9\u30f3\u30c0\u30e0\u5316\u3055\u308c\u3001\u30c1\u30e2\u30b7\u30f3 \u03b1-1 \u306f 28 \u306e\u5168\u65e5\u6b7b\u56e0\u6b7b\u4ea1\u7387\u3092\u4f4e\u4e0b\u3055\u305b\u307e\u305b\u3093\u3067\u3057\u305f\u3002<\/p>","protected":false},"author":1,"featured_media":737,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"369","pim_article_type":"Published evidence review","pim_evidence_level":"Large multicenter randomized phase 3 human trial with a neutral primary outcome","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, study size, model\/population limits and relevant conflicts are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary\/regulatory sources, factual claims, numerical results, limitations and product-evidence boundary checked for batch 3.","pim_creation_method":"The editorial workflow began with linked PubMed primary papers, systematic reviews, PubChem identity records and FDA\/DailyMed regulatory records. Population or model, denominators, endpoints, numerical results, null findings, limitations and conflicts were extracted before drafting. AI-assisted drafting and original image generation were used; the final facts and evidence boundaries were checked against the linked records on 2026-09-02. This is not independent peer review.","pim_sources":"[{\"title\":\"TESTS phase 3 thymosin alpha-1 sepsis trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39814420\/\",\"note\":\"Primary 2025 multicenter trial; PMID 39814420.\"},{\"title\":\"2025 thymosin alpha-1 sepsis meta-analysis\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40969554\/\",\"note\":\"Eleven RCTs with quality and trial-sequential analyses; PMID 40969554.\"},{\"title\":\"PubChem Thymalfasin record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Thymalfasin\",\"note\":\"Sequence, formula, mass and synonym record; CID 16130571.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result<\/title>\n<meta name=\"description\" content=\"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/ja\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\" \/>\n<meta property=\"og:description\" content=\"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/ja\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T16:45:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\"},\"wordCount\":272,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\",\"name\":\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"datePublished\":\"2026-09-01T16:45:45+00:00\",\"description\":\"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/thymosin-alpha1-sepsis-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: Multicenter two-arm sepsis trial data visualization with near-overlapping outcomes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/ja\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u6557\u8840\u75c7\u306e Thymosin Alpha-1: 2025 TESTS \u30d5\u30a7\u30fc\u30ba 3 \u306e\u7d50\u679c","description":"2025 TESTS \u8a66\u9a13\u306f\u3001\u4ee5\u524d\u306e\u5c0f\u898f\u6a21\u306a\u6557\u8840\u75c7\u5831\u544a\u3088\u308a\u3082\u6709\u76ca\u3067\u3059\u30021,106 \u6210\u4eba\u306f 22 \u30bb\u30f3\u30bf\u30fc\u5168\u4f53\u3067\u30e9\u30f3\u30c0\u30e0\u5316\u3055\u308c\u3001\u30c1\u30e2\u30b7\u30f3 \u03b1-1 \u306f\u691c\u51fa\u3055\u308c\u307e\u305b\u3093\u3067\u3057\u305f\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/ja\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","og_locale":"ja_JP","og_type":"article","og_title":"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result","og_description":"The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1 did not re\u2026","og_url":"https:\/\/nhdbio.com\/ja\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","og_site_name":"NHD","article_published_time":"2026-09-01T16:45:45+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u57f7\u7b46\u8005":"NHD Technical Team","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result","datePublished":"2026-09-01T16:45:45+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"},"wordCount":272,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"ja","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","url":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/","name":"\u6557\u8840\u75c7\u306e Thymosin Alpha-1: 2025 TESTS \u30d5\u30a7\u30fc\u30ba 3 \u306e\u7d50\u679c","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","datePublished":"2026-09-01T16:45:45+00:00","description":"2025 TESTS \u8a66\u9a13\u306f\u3001\u4ee5\u524d\u306e\u5c0f\u898f\u6a21\u306a\u6557\u8840\u75c7\u5831\u544a\u3088\u308a\u3082\u6709\u76ca\u3067\u3059\u30021,106 \u6210\u4eba\u306f 22 \u30bb\u30f3\u30bf\u30fc\u5168\u4f53\u3067\u30e9\u30f3\u30c0\u30e0\u5316\u3055\u308c\u3001\u30c1\u30e2\u30b7\u30f3 \u03b1-1 \u306f\u691c\u51fa\u3055\u308c\u307e\u305b\u3093\u3067\u3057\u305f\u3002","breadcrumb":{"@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/thymosin-alpha1-sepsis-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: Multicenter two-arm sepsis trial data visualization with near-overlapping outcomes"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/thymosin-alpha-1-tests-phase-3-sepsis-trial-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Thymosin Alpha-1 in Sepsis: The 2025 TESTS Phase 3 Result"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u30da\u30d7\u30c1\u30c9\u539f\u6599\u30fb\u30ab\u30b9\u30bf\u30e0\u30da\u30d7\u30c1\u30c9\u5408\u6210","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD \u30c6\u30af\u30cb\u30ab\u30eb\u30c1\u30fc\u30e0","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"NHD \u6280\u8853\u30c1\u30fc\u30e0\u306f\u3001\u7814\u7a76\u7528\u306e\u30ab\u30bf\u30ed\u30b0\u6587\u66f8\u3068\u8a3c\u62e0\u306e\u6982\u8981\u3092\u7ba1\u7406\u3057\u307e\u3059\u3002\u67fb\u8aad\u6e08\u307f\u306e\u8ad6\u6587\u306f\u3001\u67fb\u8aad\u6e08\u307f\u306e\u8ad6\u6587\u3001\u6cbb\u9a13\u767b\u9332\u304a\u3088\u3073\u898f\u5236\u8a18\u9332\u306b\u30ea\u30f3\u30af\u3057\u3066\u304a\u308a\u3001\u7121\u52b9\u306a\u6240\u898b\u3084\u7814\u7a76\u306e\u9650\u754c\u3092\u4fdd\u6301\u3057\u3001\u30ab\u30bf\u30ed\u30b0\u8cc7\u6599\u304b\u3089\u51fa\u7248\u3055\u308c\u305f\u4ecb\u5165\u3092\u533a\u5225\u3057\u307e\u3059\u3002 AI \u3092\u5229\u7528\u3057\u305f\u88fd\u56f3\u3092\u69cb\u9020\u306b\u4f7f\u7528\u3067\u304d\u307e\u3059\u3002\u30bd\u30fc\u30b9\u30ea\u30f3\u30af\u3068\u8a3c\u62e0\u306e\u5883\u754c\u306f\u8868\u793a\u3055\u308c\u305f\u307e\u307e\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u306e\u7814\u7a76\u306f\u72ec\u7acb\u3057\u305f\u67fb\u8aad\u3084\u533b\u5b66\u7684\u30a2\u30c9\u30d0\u30a4\u30b9\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/ja\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/comments?post=753"}],"version-history":[{"count":0,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/753\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media\/737"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media?parent=753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/categories?post=753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/tags?post=753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}